Literature DB >> 9070886

Pretreatment by tubulin agents decreases C-MYC induction in human colon carcinoma cell line HT29-D4.

S el Khyari1, V Bourgarel, Y Barra, D Braguer, C Briand.   

Abstract

For HT29-D4 cell line, we confirmed the interaction between c-Myc protein and microtubules by immunoprecipitation. We then studied the effect of antimitotic agents, nocodazole and the taxoids [paclitaxel (taxol) and docetaxel (taxotere)] on c-myc oncogene expression. The expression was analyzed by RT-PCR and Western blot. Taxol (1 microM), taxotere (1 microM) and nocodazole (3 microM) inhibited by 30-50% the c-myc induction produced by growth factors in culture medium. According to the flow cytometry analysis, the inhibition is not linked to the mitotic block. These results observed for both stabilizing and depolymerizing agents suggest that microtubular system is involved in c-myc expression more through its dynamic properties which influence signal transduction and intracellular transports than through its direct interaction with c-Myc protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070886     DOI: 10.1006/bbrc.1997.6187

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.

Authors:  G M Bahr; E C Darcissac; N Castéran; C Amiel; C Cocude; M J Truong; J Dewulf; A Capron; Y Mouton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Low-dose paclitaxel downregulates MYC proto-oncogene bHLH transcription factor expression in colorectal carcinoma cells.

Authors:  Wenjing Li; Wanyun Zhu; Chaoxiang Lv; Hao Qu; Kaixiang Xu; Honghui Li; Haifeng Li; Yiming Du; Guangming Liu; Yunyue Wang; Hong-Jiang Wei; Hong-Ye Zhao
Journal:  Oncol Lett       Date:  2017-12-05       Impact factor: 2.967

3.  Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.

Authors:  Suwit Duangmano; Phorntip Sae-Lim; Apichart Suksamrarn; Frederick E Domann; Pimpicha Patmasiriwat
Journal:  BMC Complement Altern Med       Date:  2012-10-12       Impact factor: 3.659

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.